Loading company…
Nventric designs and manufactures medical devices for vascular, coronary, neurovascular, and structural heart conditions.
Founded in 2019 and based in California, Nventric develops and sells medical devices for neurovascular, electrophysiology, coronary, peripheral, and structural heart applications. In June 2026, it raised KRW 34.5 billion in pre-IPO funding from Loftyrock Investment, MONEYBALL VENTURES, Moneyball Partners, Scale Up Partners, Shinhan Venture Investment, AJU IB Investment, HB Investment, LB Investment, Pacific Capital, Plexus Partners, and Heungkuk Securities. Returning investors included Shinhan Capital, IPS Ventures, and QUAD Ventures. The company planned to use the funding to support global expansion and IPO preparation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in